Jeff Huntsman is the Chief Commercial Officer, responsible for the overall commercial strategy and revenue generation for EmVenio Research. Mr. Huntsman joined EmVenio in 2024 with more than 30 years of experience in the Life Sciences space, where he has led global commercial teams selling pharma services and site solutions across the clinical development and regulatory lifecycle.
Prior to joining EmVenio, Mr. Huntsman ran a consulting firm providing strategic advice to private equity, venture capital and emerging growth companies. Earlier in his career, he was the Chief Commercial Officer at Sitero, Citeline, ConnectiveRx, Parexel and LIQUENT. He has held executive leadership roles at Clarivate, Thomson Reuters, and Rogers Communications as well as having served as a Health Care Advisor at Warburg Pincus and Growth Capital Partners.